Dignitana CEO Catarina Löwenadler interviewed by Redeye
Dignitana Release - wkr0006.pdf
Dignitana CEO Catarina Löwenadler was interviewed by Redeye analyst Mats Hyttinge today. The interview highlights Dignitana's growth and strategic priorities as published in the May 25th Q1 Interim Report titled "Revenue reaches record high with EBITDA positive."
Watch the video interview in Swedish here: Dignitana: Videointervju med vd Catarina Löwenadler
For an English translation of the interview text email investorrelations@dignitana.com.
For More Information Contact
Melissa Bourestom, Chief Communications Officer, melissa.bourestom@dignitana.com +1 469-518-5031
About Dignitana
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.
Dignitana nominated for inaugural Texas Impact Enterprise Awards
Dignitana invited to address MedTech innovation on panel at SXSW® conference in Texas
Dignitana newsletter presents accelerating growth in US and around the globe
Dignitana convenes Training Academy bringing distributors to Lund Headquarters